Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2003
09/12/2003WO2003073935A2 Breath collection system
09/12/2003WO2003073911A2 Method and composition for detection and treatment of breast cancer
09/12/2003WO2003073910A2 Assays for cancer patient monitoring based on levels of analyte components of the plasminogen activator system in body fluid samples
09/12/2003WO2003073909A2 Assays to monitor levels of epidermal growth factor receptor (egfr) extracellular domain (ecd) in cancer patients
09/12/2003WO2003073841A2 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
09/12/2003WO2003073826A2 Novel compositions and methods for cancer
09/12/2003WO2003073823A2 PDPK1s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
09/12/2003WO2003073822A2 Methods of diagnosing liver fibrosis
09/12/2003WO2003073821A2 Shc PROTEIN-RELATED METHODS AND COMPOSITIONS FOR THE PROGNOSIS OF BREAST, PROSTATE AND OVARIAN CANCER
09/12/2003WO2003073818A2 Proteomic analysis of tumors for development of consultative report of therapeutic options
09/12/2003WO2003073817A2 Rapid and sensitive detection of cells and viruses
09/12/2003WO2003056033A8 Non- or minimally invasive monitoring methods
09/12/2003WO2003053535A3 Nanoparticle imaging system and method
09/12/2003WO2003052375A3 Device and methods for monitoring the status of at least one cell
09/12/2003WO2003051374A3 SEQUESTRATION OF Aβ IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
09/12/2003WO2003048736A3 Microfluidic device and surface decoration process for solid phase affinity binding assays
09/12/2003WO2003046505A3 Device for detecting carbon dioxide and method for determining a microbiological contamination of a fluid
09/12/2003WO2003046133A3 Regulatory nucleic acid assay for diagnostic and library screens
09/12/2003WO2003032814A3 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
09/12/2003WO2003031063A3 Device for holding a substance library carrier
09/12/2003WO2003025568A3 Identification of antigens by xenogenic, allogenic or autologous antibody-mediated precipitation
09/12/2003WO2003025212A3 Method for detecting sepsis
09/12/2003WO2003021853A3 Apparatus for reading signals generated from resonance light scattered particle labels
09/12/2003WO2003018757A3 Stabilization of cells and biological specimens for analysis
09/12/2003WO2003012443A3 Rapid diagnostic device, assay and multifunctional buffer
09/12/2003WO2003010544A3 Method for the diagnosis of kidney damage in the early stages
09/12/2003WO2003007794A3 Invasion complex and methods of targeting
09/12/2003WO2003003017A3 Use of transcription factor nak-1 or genes regulated by transcription factor nak-1 for the diagnosis and/or therapy of inflammatory and malignant diseases
09/12/2003WO2003001201A3 Method for the extra-corporeal qualitative and/or quantitative recording of neuro-toxic substances in the blood plasma of an individual
09/12/2003WO2002097132A3 Nucleic acid detection method
09/12/2003WO2002094976A3 Identification of antimicrobial agents
09/12/2003WO2002090983A3 Quantitative single-step immunoassay in lyophilised form
09/12/2003WO2002090569A3 Family-based association tests for quantitative traits using pooled dna
09/12/2003WO2002088314A3 Ovary-specific genes and proteins
09/12/2003WO2002082080A3 Method for producing a plurality of identical copies of a two-dimensional test array of probe molecules
09/12/2003WO2002082041A3 Production and use of novel peptide-based agents for use with bi-specific antibodies
09/12/2003WO2002075507A3 Anti-bacterial vaccine compositions
09/12/2003WO2002072830A3 Proteins associated with cell growth, differentiation, and death
09/12/2003WO2002070736A3 Method for the detection of nucleic acid molecules
09/12/2003WO2002068682A3 Method for identifying biologically active structures of microbial pathogens
09/12/2003WO2002062205A3 Methods for diagnosing and treating heart disease
09/12/2003WO2002054080A3 Proteins, genes and their use for diagnosis and treatment of vascular response
09/12/2003WO2002050547A3 Fluorescent dye complexes
09/12/2003WO2002050546A3 Method and use of the cytosolic nadp-dependent malate-decarboxylase isoenzyme for identifying a malignant process, and a suitable test kit
09/12/2003WO2002048370A3 Compositions and methods relating to colon specific genes and proteins
09/12/2003WO2002046468A3 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
09/12/2003WO2002046464A3 Ligand detection method
09/12/2003WO2002044420A3 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
09/12/2003WO2002038794A3 Cardiovascular disease diagnostic and therapeutic targets
09/12/2003WO2002036616A3 Compositions and methods relating to breast specific genes and proteins
09/12/2003WO2002032961A8 Novel polypeptides and nucleic acids encoding same
09/12/2003WO2002031191A3 Dendritically amplified detection method
09/12/2003WO2002030256A9 Diagnostic indicator of thymic function
09/12/2003WO2002029015A9 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor
09/12/2003WO2002027317A3 Conjugates of defined stoichiometry
09/12/2003WO2002017969A9 Reagents and methods for the diagnosis of cmv dissemination
09/12/2003WO2002008755A3 Identifying antigen clusters for monitoring a global state of an immune system
09/12/2003WO2002008754A9 Spatially resolved enzyme-linked assay
09/12/2003WO2002004956A3 Method of identifying conformation-sensitive binding peptides and uses thereof
09/12/2003WO2002002488A9 Methods and compounds for modulating nuclear receptor coactivator binding
09/12/2003WO2001096597A3 High throughput screening of compounds for biological activity
09/12/2003WO2001094528A9 Visual-servoing optical microscopy
09/12/2003WO2001071031A3 Carrier for gene detection and its use for detecting validity of interferon therapy
09/12/2003WO2001046693A3 Screening under isothermal denaturing conditions
09/12/2003WO2000065421A3 Receptor selectivity mapping
09/12/2003CA2754415A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2754186A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and anaylses
09/12/2003CA2754185A1 Labeling reagents and labeled targets, target labeling processes and other processes or using same in nucleic acid determinations and analyses
09/12/2003CA2754041A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753922A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2753910A1 Labeling reagents and labeled targets, target labeling processes and other processes for using same in nucleic acid determinations and analyses
09/12/2003CA2674835A1 Real-time nucleic acid detection processes and compositions
09/12/2003CA2478493A1 Method and device for determination of tissue specificity of free floating dna in bodily fluids
09/12/2003CA2478298A1 Microarrays of cellulose binding chimeric proteins and methods of use thereof
09/12/2003CA2478288A1 Scd fingerprints
09/12/2003CA2478168A1 Method for monitoring the quality of a herbal medicine
09/12/2003CA2478042A1 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents
09/12/2003CA2477974A1 Novel compositions and methods for cancer
09/12/2003CA2477953A1 Shc protein-related methods and compositions for the prognosis of breast, prostate and ovarian cancer
09/12/2003CA2477921A1 Absorbing organic reagent into diagnostic test devices by formation of amine salt complexes
09/12/2003CA2477876A1 Recombinant protein c variants
09/12/2003CA2477749A1 Artificial receptors, building blocks, and methods
09/12/2003CA2477738A1 Therapeutic properties of oils
09/12/2003CA2477662A1 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
09/12/2003CA2477621A1 Determination of compatibility of a set of chemical modifications with an amino-acid chain
09/12/2003CA2477590A1 Sumo inhibitors
09/12/2003CA2477400A1 Treatment for asthma or allergies
09/12/2003CA2477151A1 Method for protein identification using mass spectrometry data
09/12/2003CA2476979A1 Assay for anti-ingap antibodies
09/12/2003CA2476410A1 Methods to increase or decrease bone density
09/12/2003CA2475690A1 Diagnostic method for glaucoma
09/12/2003CA2475306A1 Methods for absolute cell counting
09/12/2003CA2466220A1 Phage ligand sensor devices and uses thereof
09/12/2003CA2460212A1 Rapid and sensitive detection of cells and viruses
09/12/2003CA2421556A1 Real-time nucleic acid detection processes and compositions
09/11/2003US20030172390 Mo54 gene disruptions, compositions and methods related thereto
09/11/2003US20030172389 Surfactant protein D for the prevention and diagnosis of pulmonary emphysema
09/11/2003US20030172388 Methods and compositions relating to fortilin, an anti-apoptotic molecule, and modulators of fortilin
09/11/2003US20030171873 Method and apparatus for grouping proteomic and genomic samples
09/11/2003US20030171698 Conductivity-normalized urinary analyte concentration measurement for use in disease diagnosis
1 ... 2510 2511 2512 2513 2514 2515 2516 2517 2518 2519 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 ... 3937